Table 4

Qualitative variables by group.

VariableDeformity, n (%)Degenerative Disease, n (%) P Value
Gender
 Men4 (44.4)4 (22.2)
 Women5 (55.6)14 (77.8)0.375
Revision surgery
 Yes2 (22.2)7 (38.9)
 No7 (77.8)11 (61.1)0.667
Area
 Thoracic spine1 (11.1)1 (5.6)
 Lumbar spine3 (33.3)16 (88.9)
 Thoracolumbar spine5 (55.6)1 (5.6)0.003
No. of segments fused
 21 (11.1)8 (44.4)
 33 (33.3)8 (44.4)
 43 (33.3)2 (11.1)
 52 (22.2)0 (0.0)0.057
Antibiotic prophylaxis
 Cefazolin4 (44.4)13 (72.2)
 Vancomycin1 (11.1)0 (0.0)
 Cefazolin + aminoglycoside3 (33.3)4 (22.2)
 Cefazolin + gentamicin + rifampicin0 (0.0)1 (5.6)
 Unspecified1 (11.1)0 (0.0)0.207
Obesity (by body mass index [kg/m2])
 <305 (55.6)7 (43.8)
 30–353 (33.3)8 (50.0)
 >351 (11.1)1 (6.2)0.840
Smoking
 Yes1 (11.1)0 (0.0)
 No8 (88.9)18 (100)0.333
No malnutrition8 (100)18 (100)0.050
American Society of Anesthesiologists class
 II1 (11.1)9 (50.0)
 III8 (88.9)9 (50.0)0.091
History of infection
 Yes1 (11.1)0 (0.0)
 No8 (88.9)18 (100)0.333
Early infection8 (100)18 (100)0.050
Deep infection level9 (100)18 (100)0.083
Bacteria
 Gram-positive3 (33.3)7 (38.9)
 Gram-negative4 (44.4)3 (16.7)
 Polymicrobial2 (22.2)8 (44.4)0.268
Measurement of C-reactive protein level
 Performed0 (0.0)1 (5.9)
 Not performed7 (100)16 (94.1)1.000
Sonication
 Performed1 (12.5)1 (5.6)
 Not performed7 (87.5)17 (94.4)0.529
Pathogen concordance
 Yes4 (44.4)9 (50.0)
 No5 (55.6)9 (50.0)1.000
No. of irrigations
 13 (33.3)10 (55.6)
 24 (44.4)7 (38.9)
 31 (11.1)0 (0.0)
 40 (0.0)1 (5.6)
 61 (11.1)0 (0.0)0.303
Plastic surgery
 Yes3 (33.3)2 (11.1)
 No6 (66.7)16 (88.9)0.295
Vacuum-assisted closure therapy
 Yes4 (44.4)2 (11.1)
 No5 (55.6)16 (88.9)0.136